Contributions
Dr. Maggie Cadet: Advancing Rheumatoid Arthritis Research
In this MD Newsline exclusive interview with rheumatologist Dr. Maggie Cadet, we discuss recent advancements in rheumatoid arthritis research. We also discuss how to improve the inclusion of diverse participants and diverse leadership in arthritis clinical trials. MD Newsline: Is there any research that excites you or that you think is important for physicians to...
Dr. Maggie Cadet: Managing Rheumatoid Arthritis
In this MD Newsline exclusive interview with rheumatologist Dr. Maggie Cadet, we discuss Dr. Cadet’s treatment strategy for rheumatoid arthritis. We also discuss the importance of helping patients understand and prevent the complications of rheumatoid arthritis. MD Newsline: What is your treatment strategy for rheumatoid arthritis, and how is it tailored to each patient? How...
Dr. Maggie Cadet: Rheumatoid Arthritis Disparities
In this MD Newsline exclusive interview with rheumatologist Dr. Maggie Cadet, we discuss the disparities experienced by minority populations with rheumatoid arthritis. We also discuss the role of socioeconomic status and education in arthritis management and how to rectify rheumatoid arthritis disparities. MD Newsline: Why do African Americans, Hispanic Americans, and American Indians/Alaska Natives experience...
Dr. Maggie Cadet: Rheumatoid Arthritis and the Pandemic
In this MD Newsline exclusive interview with rheumatologist Dr. Maggie Cadet, we discuss rheumatoid arthritis management challenges and disparities during the COVID-19 pandemic. MD Newsline: What are the biggest challenges that rheumatologists are tasked with in the wake of COVID-19? Dr. Maggie Cadet: “It has been challenging to assuage our patients’ fears of getting vaccinated for COVID-19....
Dr. Valerie Harvey on her Vitiligo Treatment Strategy
In this MD Newsline exclusive interview with dermatologist Dr. Valerie Harvey, we discuss Dr. Harvey’s vitiligo treatment strategy. MD Newsline: What is your treatment strategy for vitiligo, and how is it tailored to each patient? Dr. Valerie Harvey: “Which treatment I use for vitiligo depends on how much of the patient’s skin is affected by...
Racial Disparities in Cervical Cancer Prevention
This year, it is estimated that 14,100 women will be diagnosed with invasive cervical cancer in the United States [1]. When compared to non-Hispanic white women, African American women have a significantly higher rate of cervical cancer and a higher death rate from cervical cancer. These statistics call for a deeper understanding of why a...
The High Costs of ATTR-CM
The cardiac presentation of transthyretin amyloidosis, otherwise known as transthyretin amyloid cardiomyopathy (ATTR-CM), can be life-threatening. Without proper support and treatment, ATTR-CM can cause heart failure (HF). Given the severe nature of the disease, patients with ATTR HF may experience higher costs of care than those with non-ATTR HF. This study, published in ESC Heart...
Racial Disparities in Transthyretin Amyloid Cardiomyopathy
Transthyretin amyloid cardiomyopathy (ATTR-CM) is a life-threatening heart condition historically considered a rare disease. Left untreated, ATTR-CM can lead to heart failure and other heart complications. Several mutations in the TTR gene are associated with the development of the disease. The V122I mutation is the most common variant in the United States, and around 4% of...
Dr. Alecia Nero: Providing Culturally Sensitive Care
In this MD Newsline exclusive interview with Dr. Alecia Nero, hematologist and associate professor in internal medicine and pediatrics at UT Southwestern Medical Center, we discuss how to provide culturally sensitive care and overcome language barriers. Dr. Nero is the Director of UT Southwestern’s Transition Sickle Cell Program and Adult Sickle Cell Program. UT...